Les nouveaux défis de l'ostéoporoseThérapie (Paris). 2003, Vol 58, Num 5, issn 0040-5957, 88 p.Conference Proceedings

Apoptosis - From signalling pathways to therapeutic toolsDIEDERICH, Marc; GIELEN, Jacques; PIETTE, Jacques et al.Biochemical pharmacology. 2003, Vol 66, Num 8, issn 0006-2952, 357 p.Conference Proceedings

Notions de base de pharmacologie. I: Les étapes du développement d'un médicament = PharmacologyBENTUE-FERRER, D; LACROIX, P; REYMANN, J. M et al.Angéiologie (Paris). 1995, Vol 47, Num 3, pp 43-52, issn 0003-3049Article

Cicletanine: biology, pharmacology and clinical sciencesBRAQUET, P; GUINOT, P; TARRADE, T et al.Drugs under experimental and clinical research. 1988, Vol 14, Num 2-3, pp 71-230, issn 0378-6501Serial Issue

6'7'-Dihydroxybergamottin contributes to the grapefruit juice effectKAKAR, Shefali M; PAINE, Mary F; STEWART, Paul W et al.Clinical pharmacology and therapeutics. 2004, Vol 75, Num 6, pp 569-579, issn 0009-9236, 11 p.Article

p73 and p63 protein stability: the way to regulate function?MAISSE, Carine; GUERRIERI, Piero; MELINO, Gerry et al.Biochemical pharmacology. 2003, Vol 66, Num 8, pp 1555-1561, issn 0006-2952, 7 p.Conference Paper

Abstract Book 2011 European Multidisciplinary Cancer Congress (ECCO16, ESMO36, ESTRO30): integrating basic & translational science, surgery, radiotherapy, medical oncology, advocacy & care, Stockholm, 23-27 September 2011European journal of cancer. Supplement (1990). 2011, Vol 47, Num 1, issn 1359-6349, 773 p.Conference Proceedings

Moving Forward with New Data and Approaches: A Fresh Look at Anthracyclines in Breast Cancer. Summary of a workshop held in September 2010AMADORI, Dino; AAPRO, Matti.European journal of cancer. Supplement (1990). 2011, Vol 9, Num 2, issn 1359-6349, 44 p.Serial Issue

Improving outcome by targeted delivery in Breast Cancer: A review of nab^TM-paclitaxel (nanoparticle albumin-bound paclitaxel)European journal of cancer. Supplement (1990). 2010, Vol 8, Num 1, issn 1359-6349, 20 p.Serial Issue

EBCC 7: European Breast Cancer Conference, 24-27 March 2010, Barcelona , SpainEuropean journal of cancer. Supplement (1990). 2010, Vol 8, Num 3, issn 1359-6349, 276 p.Conference Proceedings

Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancerEuropean journal of cancer. Supplement (1990). 2008, Vol 6, Num 5, issn 1359-6349, 32 p.Serial Issue

Clinical pharmacology : the first 75 years and a view of the futureDOLLERY, Colin T.British journal of clinical pharmacology. 2006, Vol 61, Num 6, pp 650-665, issn 0306-5251, 16 p.Article

Cancer Prevention 2006 - Advances in Molecular and Clinical aspects of cancer preventionEuropean journal of cancer. Supplement (1990). 2006, Vol 4, Num 1, issn 1359-6349, 72 p.Conference Proceedings

Cancer stem cells: opportunities for novel diagnostics and drug discoveryKEITH, W. Nicol.European journal of cancer (1990). 2006, Vol 42, Num 9, issn 0959-8049, 122 p.Serial Issue

Cancer in children and adolescents in EuropeSTELIAROVA-FOUCHER, Eva; COEBERGH, Jan Willem; KAATSCH, Peter et al.European journal of cancer (1990). 2006, Vol 42, Num 13, issn 0959-8049, 281 p.Serial Issue

Cancer chemoprevention - An update on a novel and exciting field of oncologyGESCHER, Andreas.European journal of cancer (1990). 2005, Vol 41, Num 13, issn 0959-8049, 205 p.Serial Issue

British pharmaceutial [sic] conference (Science proceedings, Manchester, September 26-28, 2005)Craig, Duncan.Journal of pharmacy and pharmacology. Supplement. 2005, issn 0373-1022, 1Vol, XVI-122 pConference Proceedings

Cancer Research: Back to the Future, Celebrating 40 years of the EJCSMYTH, John.European journal of cancer (1990). 2004, Vol 40, Num 13, issn 0959-8049, 93 p.Serial Issue

Annual Congress on Clinical Pharmacology, Association of Clinical PharmacologyEuropean journal of clinical pharmacology. 2001, Vol 57, Num 8, pp A15-A42, issn 0031-6970Conference Proceedings

Abstracts of papers: 2000 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, Los Angeles, California, March 14-18, 2000Clinical pharmacology and therapeutics. 2000, Vol 67, Num 2, issn 0009-9236, 105 p.Conference Proceedings

Proceedings of the British Pharmacological Society Meeting, 8th-10th September 1999, University of LeedsBritish journal of pharmacology. 1999, Vol 128, Num NOV, issn 0007-1188, 54 p., SUPConference Proceedings

Annual Meeting of the American Society for Clinical Pharmacology and TherapeuticsClinical pharmacology and therapeutics. 1999, Vol 65, Num 2, issn 0009-9236, 118 p.Conference Proceedings

Joint Meeting with the Dutch Pharmacological Society and the Belgian Society for Fundamental and Clinical Physiology and PharmacologyBritish journal of clinical pharmacology. 1998, Vol 45, Num 5, pp 503P-523P, issn 0306-5251Conference Proceedings

Annual Meeting of the American Society for Clinical Pharmacology and TherapeuticsClinical pharmacology and therapeutics. 1997, Vol 61, Num 2, pp 137-274, issn 0009-9236Conference Proceedings

Joint meeting of the British Pharmacological Society and the Nordic Pharmacological SocietiesBritish journal of pharmacology. 1996, Vol 119, Num DEC, issn 0007-1188, non paginé [52 p.], SUPConference Proceedings